_id
6911bb10ccc777a4e85d61a0
Ticker
GELS
Name
Gelteq Limited Ordinary Shares
Exchange
NASDAQ
Address
Monash Innovation Labs, Clayton, VIC, Australia, 3800
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.gelteq.com
Description
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Last Close
0.8285
Volume
14547
Current Price
0.8383
Change
0.0377
Last Updated
2026-01-03T12:29:53.090Z
Image
data:image/webp;base64,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
Ipo Date
2024-10-29T00:00:00.000Z
Market Cap
8972655
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9964999999999999
Sentiment Sources
2
Current Quarter
2024-09-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
966555
Operating Income
-966555
Interest Expense
151477
Pretax Income
-1133132
Net Income
-1133132
Eps
-0.14
Dividends Per Share
-
Shares Outstanding
10711059
Income Tax Expense
-
EBITDA
-679856
Operating Margin
-
Total Other Income Expense Net
-166577
Cash
24522
Short Term Investments
-
Receivables
183005
Inventories
-
Total Current Assets
303227
Property Plant Equipment
16642
Total Assets
20757827
Payables
387034
Short Term Debt
2084152
Long Term Debt
-
Total Liabilities
5645530
Equity
15112297
Bs_currency_symbol
-
Depreciation
301799
Change In Working Capital
-
Cash From Operations
-302150
Capital Expenditures
65060
Cash From Investing
-65060
Cash From Financing
248540
Net Change In Cash
-121339
Cf_currency_symbol
-
PE
-
PB
0.4489742717470415
ROE
-7.49807921323939
ROA
-5.458818015970554
FCF
-367210
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
5.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2024-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
966555
Quarters > 0 > income Statement > operating Income
-966555
Quarters > 0 > income Statement > interest Expense
151477
Quarters > 0 > income Statement > pretax Income
-1133132
Quarters > 0 > income Statement > net Income
-1133132
Quarters > 0 > income Statement > eps
-0.14
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8093800
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-679856
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-166577
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
24522
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
183005
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
303227
Quarters > 0 > balance Sheet > property Plant Equipment
16642
Quarters > 0 > balance Sheet > total Assets
20757827
Quarters > 0 > balance Sheet > payables
387034
Quarters > 0 > balance Sheet > short Term Debt
2084152
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5645530
Quarters > 0 > balance Sheet > equity
15112297
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-1133132
Quarters > 0 > cash Flow > depreciation
301799
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-302150
Quarters > 0 > cash Flow > capital Expenditures
65060
Quarters > 0 > cash Flow > cash From Investing
-65060
Quarters > 0 > cash Flow > cash From Financing
248540
Quarters > 0 > cash Flow > net Change In Cash
-121339
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.14
Quarters > 0 > ratios > PB
0.4489742717470415
Quarters > 0 > ratios > ROE
-7.49807921323939
Quarters > 0 > ratios > ROA
-5.458818015970554
Quarters > 0 > ratios > FCF
-367210
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
0
Quarters > 1 > income Statement > gross Profit
0
Quarters > 1 > income Statement > operating Expenses
911620
Quarters > 1 > income Statement > operating Income
-911620
Quarters > 1 > income Statement > interest Expense
151477
Quarters > 1 > income Statement > pretax Income
-1133132
Quarters > 1 > income Statement > net Income
-1133132
Quarters > 1 > income Statement > eps
-0.1200596519947129
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
9438075
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-54935
Quarters > 1 > income Statement > currency_symbol
AUD
Quarters > 1 > balance Sheet > cash
24522
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
8251
Quarters > 1 > balance Sheet > inventories
0
Quarters > 1 > balance Sheet > total Current Assets
303227
Quarters > 1 > balance Sheet > property Plant Equipment
16642
Quarters > 1 > balance Sheet > total Assets
20757827
Quarters > 1 > balance Sheet > payables
387034
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
1759447
Quarters > 1 > balance Sheet > total Liabilities
5645530
Quarters > 1 > balance Sheet > equity
15112297
Quarters > 1 > balance Sheet > currency_symbol
AUD
Quarters > 1 > cash Flow > net Income
-1133132
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
65060
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
248540
Quarters > 1 > cash Flow > net Change In Cash
-118670
Quarters > 1 > cash Flow > currency_symbol
AUD
Quarters > 1 > ratios > PE
-0.1200596519947129
Quarters > 1 > ratios > PB
0.5235430638042649
Quarters > 1 > ratios > ROE
-7.49807921323939
Quarters > 1 > ratios > ROA
-5.458818015970554
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2024-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
10097495
Quarters > 2 > income Statement > operating Income
-10097495
Quarters > 2 > income Statement > interest Expense
146852
Quarters > 2 > income Statement > pretax Income
-727419
Quarters > 2 > income Statement > net Income
-727419
Quarters > 2 > income Statement > eps
-0.07707281410669019
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
9438075
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-279744
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
9370076
Quarters > 2 > income Statement > currency_symbol
AUD
Quarters > 2 > balance Sheet > cash
145861
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
139413
Quarters > 2 > balance Sheet > inventories
95201
Quarters > 2 > balance Sheet > total Current Assets
532978
Quarters > 2 > balance Sheet > property Plant Equipment
17379
Quarters > 2 > balance Sheet > total Assets
21224320
Quarters > 2 > balance Sheet > payables
1329270
Quarters > 2 > balance Sheet > short Term Debt
1983302
Quarters > 2 > balance Sheet > long Term Debt
1458417
Quarters > 2 > balance Sheet > total Liabilities
4978891
Quarters > 2 > balance Sheet > equity
16245429
Quarters > 2 > balance Sheet > currency_symbol
AUD
Quarters > 2 > cash Flow > net Income
-727419
Quarters > 2 > cash Flow > depreciation
300823
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-339149
Quarters > 2 > cash Flow > capital Expenditures
3149
Quarters > 2 > cash Flow > cash From Investing
-3149
Quarters > 2 > cash Flow > cash From Financing
358706
Quarters > 2 > cash Flow > net Change In Cash
19077
Quarters > 2 > cash Flow > currency_symbol
AUD
Quarters > 2 > ratios > PE
-0.07707281410669019
Quarters > 2 > ratios > PB
0.48702550560529984
Quarters > 2 > ratios > ROE
-4.477684153493269
Quarters > 2 > ratios > ROA
-3.4272900144739618
Quarters > 2 > ratios > FCF
-342298
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
-1
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
-1
Quarters > 3 > income Statement > operating Expenses
833354
Quarters > 3 > income Statement > operating Income
-833355
Quarters > 3 > income Statement > interest Expense
113338
Quarters > 3 > income Statement > pretax Income
-947830
Quarters > 3 > income Statement > net Income
-947830
Quarters > 3 > income Statement > eps
-0.10042619919845944
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
9438075
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-527688
Quarters > 3 > income Statement > operating Margin
83335500
Quarters > 3 > income Statement > total Other Income Expense Net
-114475
Quarters > 3 > income Statement > currency_symbol
AUD
Quarters > 3 > balance Sheet > cash
399224
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
345291
Quarters > 3 > balance Sheet > inventories
95201
Quarters > 3 > balance Sheet > total Current Assets
990974
Quarters > 3 > balance Sheet > property Plant Equipment
10001
Quarters > 3 > balance Sheet > total Assets
22494636
Quarters > 3 > balance Sheet > payables
291270
Quarters > 3 > balance Sheet > short Term Debt
16982
Quarters > 3 > balance Sheet > long Term Debt
2471619
Quarters > 3 > balance Sheet > total Liabilities
3836144
Quarters > 3 > balance Sheet > equity
18658492
Quarters > 3 > balance Sheet > currency_symbol
AUD
Quarters > 3 > cash Flow > net Income
-947830
Quarters > 3 > cash Flow > depreciation
306804
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
15727
Quarters > 3 > cash Flow > cash From Investing
-15727
Quarters > 3 > cash Flow > cash From Financing
748229
Quarters > 3 > cash Flow > net Change In Cash
280105
Quarters > 3 > cash Flow > currency_symbol
AUD
Quarters > 3 > ratios > PE
-0.10042619919845944
Quarters > 3 > ratios > PB
0.4240395350546014
Quarters > 3 > ratios > ROE
-5.079885341216214
Quarters > 3 > ratios > ROA
-4.213582295797096
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
165645
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
165645
Annuals > 0 > income Statement > operating Expenses
5661172
Annuals > 0 > income Statement > operating Income
-5495527
Annuals > 0 > income Statement > interest Expense
1894649
Annuals > 0 > income Statement > pretax Income
-6645453
Annuals > 0 > income Statement > net Income
-6645453
Annuals > 0 > income Statement > eps
-0.6626881165533592
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
10028025
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-3527849
Annuals > 0 > income Statement > operating Margin
-3317.6534154366263
Annuals > 0 > income Statement > total Other Income Expense Net
-1149926
Annuals > 0 > income Statement > currency_symbol
AUD
Annuals > 0 > balance Sheet > cash
344648
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
459724
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1506670
Annuals > 0 > balance Sheet > property Plant Equipment
15907
Annuals > 0 > balance Sheet > total Assets
21475155
Annuals > 0 > balance Sheet > payables
182632
Annuals > 0 > balance Sheet > short Term Debt
4203855
Annuals > 0 > balance Sheet > long Term Debt
13550
Annuals > 0 > balance Sheet > total Liabilities
5670669
Annuals > 0 > balance Sheet > equity
15804486
Annuals > 0 > balance Sheet > currency_symbol
AUD
Annuals > 0 > cash Flow > net Income
-6645453
Annuals > 0 > cash Flow > depreciation
1222955
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-5521617
Annuals > 0 > cash Flow > capital Expenditures
642234
Annuals > 0 > cash Flow > cash From Investing
-736839
Annuals > 0 > cash Flow > cash From Financing
6453511
Annuals > 0 > cash Flow > net Change In Cash
320126
Annuals > 0 > cash Flow > currency_symbol
AUD
Annuals > 0 > ratios > PE
-0.6626881165533592
Annuals > 0 > ratios > PB
0.5315248178586763
Annuals > 0 > ratios > ROE
-42.0478907064741
Annuals > 0 > ratios > ROA
-30.944843005789714
Annuals > 0 > ratios > FCF
-6163851
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-37.21121072172417
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
0
Annuals > 1 > income Statement > operating Expenses
2945975
Annuals > 1 > income Statement > operating Income
-2945975
Annuals > 1 > income Statement > interest Expense
585120
Annuals > 1 > income Statement > pretax Income
-3546195
Annuals > 1 > income Statement > net Income
-3546195
Annuals > 1 > income Statement > eps
-0.375732869255648
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
9438075
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-1749179
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-600220
Annuals > 1 > income Statement > currency_symbol
AUD
Annuals > 1 > balance Sheet > cash
24522
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
183005
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
303227
Annuals > 1 > balance Sheet > property Plant Equipment
16642
Annuals > 1 > balance Sheet > total Assets
20757827
Annuals > 1 > balance Sheet > payables
387034
Annuals > 1 > balance Sheet > short Term Debt
2084152
Annuals > 1 > balance Sheet > long Term Debt
1759447
Annuals > 1 > balance Sheet > total Liabilities
5645530
Annuals > 1 > balance Sheet > equity
15112297
Annuals > 1 > balance Sheet > currency_symbol
AUD
Annuals > 1 > cash Flow > net Income
-3546195
Annuals > 1 > cash Flow > depreciation
1211896
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-1070471
Annuals > 1 > cash Flow > capital Expenditures
148170
Annuals > 1 > cash Flow > cash From Investing
-148170
Annuals > 1 > cash Flow > cash From Financing
843939
Annuals > 1 > cash Flow > net Change In Cash
-374702
Annuals > 1 > cash Flow > currency_symbol
AUD
Annuals > 1 > ratios > PE
-0.375732869255648
Annuals > 1 > ratios > PB
0.5231683461157494
Annuals > 1 > ratios > ROE
-23.465625377796638
Annuals > 1 > ratios > ROA
-17.083652349545066
Annuals > 1 > ratios > FCF
-1218641
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
79843
Annuals > 2 > income Statement > cost Of Revenue
48925
Annuals > 2 > income Statement > gross Profit
30918
Annuals > 2 > income Statement > operating Expenses
3133069
Annuals > 2 > income Statement > operating Income
-3102151
Annuals > 2 > income Statement > interest Expense
403521
Annuals > 2 > income Statement > pretax Income
-3506220
Annuals > 2 > income Statement > net Income
-3506220
Annuals > 2 > income Statement > eps
-0.37149736572341285
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
9438075
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-1876208
Annuals > 2 > income Statement > operating Margin
-3885.313678093258
Annuals > 2 > income Statement > total Other Income Expense Net
-404069
Annuals > 2 > income Statement > currency_symbol
AUD
Annuals > 2 > balance Sheet > cash
399224
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
345291
Annuals > 2 > balance Sheet > inventories
95201
Annuals > 2 > balance Sheet > total Current Assets
990974
Annuals > 2 > balance Sheet > property Plant Equipment
10000
Annuals > 2 > balance Sheet > total Assets
22494636
Annuals > 2 > balance Sheet > payables
291270
Annuals > 2 > balance Sheet > short Term Debt
16982
Annuals > 2 > balance Sheet > long Term Debt
2471619
Annuals > 2 > balance Sheet > total Liabilities
3836144
Annuals > 2 > balance Sheet > equity
18658492
Annuals > 2 > balance Sheet > currency_symbol
AUD
Annuals > 2 > cash Flow > net Income
-3506220
Annuals > 2 > cash Flow > depreciation
1226491
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-1770435
Annuals > 2 > cash Flow > capital Expenditures
75931
Annuals > 2 > cash Flow > cash From Investing
-75931
Annuals > 2 > cash Flow > cash From Financing
2030547
Annuals > 2 > cash Flow > net Change In Cash
236739
Annuals > 2 > cash Flow > currency_symbol
AUD
Annuals > 2 > ratios > PE
-0.37149736572341285
Annuals > 2 > ratios > PB
0.42373603544702326
Annuals > 2 > ratios > ROE
-18.791550785561878
Annuals > 2 > ratios > ROA
-15.586915920755509
Annuals > 2 > ratios > FCF
-1846366
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-23.12495772954423
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
147536
Annuals > 3 > income Statement > cost Of Revenue
94874
Annuals > 3 > income Statement > gross Profit
52662
Annuals > 3 > income Statement > operating Expenses
3245919
Annuals > 3 > income Statement > operating Income
-3193257
Annuals > 3 > income Statement > interest Expense
174503
Annuals > 3 > income Statement > pretax Income
-3368891
Annuals > 3 > income Statement > net Income
-3368891
Annuals > 3 > income Statement > eps
-0.35694683502726987
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
9438075
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-1979128
Annuals > 3 > income Statement > operating Margin
-2164.3917416766076
Annuals > 3 > income Statement > total Other Income Expense Net
-175634
Annuals > 3 > income Statement > currency_symbol
AUD
Annuals > 3 > balance Sheet > cash
162485
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
250666
Annuals > 3 > balance Sheet > inventories
95201
Annuals > 3 > balance Sheet > total Current Assets
720065
Annuals > 3 > balance Sheet > property Plant Equipment
40004
Annuals > 3 > balance Sheet > total Assets
23408790
Annuals > 3 > balance Sheet > payables
216725
Annuals > 3 > balance Sheet > short Term Debt
39793
Annuals > 3 > balance Sheet > long Term Debt
1460540
Annuals > 3 > balance Sheet > total Liabilities
2553396
Annuals > 3 > balance Sheet > equity
20855394
Annuals > 3 > balance Sheet > currency_symbol
AUD
Annuals > 3 > cash Flow > net Income
-3368891
Annuals > 3 > cash Flow > depreciation
1215260
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
1487736
Annuals > 3 > cash Flow > net Change In Cash
-19179
Annuals > 3 > cash Flow > currency_symbol
AUD
Annuals > 3 > ratios > PE
-0.35694683502726987
Annuals > 3 > ratios > PB
0.37909978720612997
Annuals > 3 > ratios > ROE
-16.153571589201334
Annuals > 3 > ratios > ROA
-14.391564023599681
Annuals > 3 > ratios > FCF
-
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
41
Valuation > metrics > PE
-0.14
Valuation > metrics > PB
0.4489742717470415
Valuation > final Score
70
Valuation > verdict
55.1% Undervalued
Profitability > metrics > ROE
-7.49807921323939
Profitability > metrics > ROA
-373.6909971737345
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3735719328438291
Risk > metrics > Interest Coverage
-6.380869702991213
Risk > final Score
34
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.12270504931640111
Liquidity > metrics > Quick Ratio
0.12270504931640111
Liquidity > final Score
16
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
30
Prev Risks > 0
36
Prev Risks > 1
-215
Prev Risks > 2
31
Prev Liquidities > 0
49
Prev Liquidities > 1
17
Prev Liquidities > 2
100
Updated At
2026-01-20T21:53:37.196Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-17
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.34
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.34
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.38
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.38
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-11-15
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.14
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.14
Earnings History > 2 > surprise Percent
-
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AUS Vaginal Atrophy Treatment Market Size, Share [2034] Fortune Business Insights
Read more →Showing 2 of 10
(Last Updated 2024-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Gelteq Limited Ordinary Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.34
EPS Estimate
0
EPS Difference
-0.34
Surprise Percent
0%
(Last Updated 2024-09-30)
(Last Updated 2024-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.